Samples were collected from various Institutes in India and we have an MOU with those Institutes regarding confidentiality of the results. Hence, we can not disclose the name of the Institute from where the sample is collected. However, we can provide the raw data as Supplementary file with the names of the organizations masked. Data are from the Sero-prevalence of rodent pathogens in India study whose authors may be contacted at <sgramachandra@gmail.com>.

Introduction {#sec001}
============

The suitability of an animal species for a specific experiment is dictated by the physiology of the animal \[[@pone.0131706.ref001]\]. Pathogens of laboratory rodents cause subclinical infections which can influence physiological and pharmacological parameters, potentially influencing the interpretation and outcome of experiments conducted on such animals \[[@pone.0131706.ref002]\], \[[@pone.0131706.ref003]\]. Several microorganisms are known to influence the function of various organ systems, affecting normal physiological values of indicator biomolecules in mice, rats and rabbits, without causing clinical signs \[[@pone.0131706.ref004]\]. Subclinical infections may also be exacerbated to produce overt disease by experimental procedures. Such infections may also increase variability among experimental animals, resulting in usage of more number of animals to achieve statistically significant results, further leading to misinterpretations or inconclusive results. Therefore, the use of minimum number of experimental animals that are free from unwanted microorganisms is an important pre-requisite to achieve reliable and reproducible results. Consequently, the microbiological status of both individual animals and the population as a whole, and therefore periodic and systematic health monitoring, plays a critical role in assessing the quality and the suitability of laboratory animals for experiments \[[@pone.0131706.ref005]\], \[[@pone.0131706.ref006]\]. Proper health monitoring is also important to validate the efficiency of measures undertaken to prevent the introduction of pathogens.

The identification of agents prevalent at individual or population level can be achieved by sero-epidemiology or other studies \[[@pone.0131706.ref007]\]. Following initiatives in the US and Japan in the 1980s, microbiological monitoring of laboratory animals was expanded to 100 mouse and rat pathogens which potentially interfere with biomedical research. In 1994, the WHO and the International Council for Laboratory Animal Science (ICLAS) published guidelines for the breeding and care of laboratory animals, and this included health monitoring \[[@pone.0131706.ref008]\], \[[@pone.0131706.ref009]\]. In Europe, frequent monitoring is recommended only for the most prevalent agents, with less frequent monitoring for the rare agents \[[@pone.0131706.ref010]\]. A number of suggestions for establishing health monitoring programmes have been published in the past few decades \[[@pone.0131706.ref011]--[@pone.0131706.ref013]\] and the importance of global standards and harmonization has also been stressed \[[@pone.0131706.ref014]\].

India has emerged as a significant player in the global biotech arena, with large-scale outsourcing of work by several pharmaceutical drug discovery firms. Consequently, state-of-the-art facilities established by many contract research organizations and pharmaceutical industries have opted for accreditation of their vivaria by India's National Good Laboratory Practice Compliance Monitoring Authority as well as the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), USA, in order that study reports are acceptable globally. However, these have been mostly need-based and driven by regulatory requirements, and not standard practices. Of the more than 1400 animal facilities registered with the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), which regulates animal experimentation in India, very few meet international standards and many do not have health monitoring programmes due to prohibitive costs. In addition, no systematic data is available on the prevalence of laboratory rodent pathogens in India. The present study was undertaken to determine the prevalence of various rodent pathogens in laboratory animals in some parts of India where majority of the animal facilities are located.

Materials and Methods {#sec002}
=====================

Collection of Samples {#sec003}
---------------------

Serum samples (500 μL) were sought from five mice and five rats maintained at 26 vivaria in public and private organizations located in different parts of India. These samples were either collected by a veterinarian or by the trained personnel under the supervision of a veterinarian. Majority of the animal facilities obtained Institutional Animal Ethics Committee (IAEC) approval specific to the health monitoring programme in their respective institutes/organizations, and the rest collected serum samples from the control group of animals from the on-going IAEC approved animal experiments. The sera were shipped on freezer packs and stored at -80°C until further analysis.

Enzyme-linked Immunosorbent Assay (ELISA) {#sec004}
-----------------------------------------

The serum samples were analyzed for the presence or absence of antibodies against for minute virus of mice (MVM), ectromelia virus (ECTV), lymphocytic choriomeningitis virus (LCMV), mouse hepatitis virus (MHV), Sendai virus (SeV), and *Mycoplasma pulmonis* in mice, and SeV, rat parvovirus (RPV), Kilham's rat virus (KRV) and sialodacryoadenitis virus (SDAV) in rats, by sandwich ELISA \[[@pone.0131706.ref015]\], using commercial kits (XpressBio Life Science Products, Thurmont, MD, USA), as per instructions provided by the manufacturer. Briefly, 100 μL of 50-fold diluted test, negative control and positive control sera were pipetted into appropriate wells, covered and incubated at 37°C for 45 min. The wells were then washed thoroughly five times, filled with 100 μL per well of ready-to-use peroxidase conjugate, and incubated at 37°C for 45 min. The wells were washed again, and a 100 μL of ready-to-use ABTS \[2,2\'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)\] peroxidase substrate was added to each well before incubating at room temperature for 30 min. The extent of reactivity was extrapolated from the colorimetric reaction which was assessed by reading absorbance at 405 nm. The sample was considered positive if the difference in absorbance of the sample between the Positive Viral Antigen well and the Negative Control Antigen well was ≥ 0.300.

Statistical Analysis and Generation of Graphs {#sec005}
---------------------------------------------

The data between samples from government and private organizations as well as between those from North and South India were analysed for statistical significance by the paired *t*-test. GraphPad Prism (Version 5) was used for the preparation of graphs. EPI-Infosoftware (Centres for Disease Control and Prevention, Atlanta, USA) and digitized maps of India were used for preparing distribution of pathogens.

Results {#sec006}
=======

One hundred and thirty serum samples each from mice and rats were analyzed for six pathogens of mice and four pathogens of rats by ELISA. For the examined set of pathogens, 53.84% of the mice were found to be infected with one or more pathogens whereas the rate of infection in rats was substantially lower (20%).

In mice, the incidence of MHV was high (46.92%), and this was followed by *Mycoplasma pulmonis* (22.30%) and MVM (13.84%). On the other hand, the incidence of SeV and LCMV were very low (2.30% and 0.76%, respectively), and none of the samples were positive for ECTV ([Table 1](#pone.0131706.t001){ref-type="table"}). In rats, the incidence was highest for SDAV (16.15%); 5.38% of the samples were positive for RPV, and none of the samples were positive for SeV or KRV ([Table 1](#pone.0131706.t001){ref-type="table"}).

10.1371/journal.pone.0131706.t001

###### Incidence of various pathogens in mice and rats.

![](pone.0131706.t001){#pone.0131706.t001g}

  Pathogen                                    Mice     Rats             
  ------------------------------------------- -------- ------- -------- -------
  Mouse hepatitis virus (MHV)                 61/130   46.92            
  *Mycoplasma pulmonis*                       29/130   22.30            
  Minute virus of mice (MVM)                  18/130   13.84            
  Sendai virus (SeV)                          3/130    2.30    0/130    0.00
  Lymphocytic choriomeningitis virus (LCMV)   1/130    0.76             
  Ectromelia virus (ECTV)                     0/130    0.00             
  Sialodacryoadenitis virus (SDAV)                             21/130   16.15
  Rat parvovirus (RPV)                                         7/130    5.38
  Kilham's rat virus (KRV)                                     0/130    0.00

Fifty four per cent of the sera tested positive for one or the other agent, and multiple infections were common, with 14.75% of the sera being positive for three or more agents. In mice, MHV appeared to co-exist with other pathogens (55.74%) rather than singly (39.34%). On the other hand, MVM was never found singly ([Table 2](#pone.0131706.t002){ref-type="table"}). Whereas all the positive samples from rats were for parvoviruses, 11.54% of the samples were positive for both RPV and SDAV, while 73.08% were positive for SDAV only.

10.1371/journal.pone.0131706.t002

###### Prevalence (no. of positive samples) of multiple infections in mice and rats.

![](pone.0131706.t002){#pone.0131706.t002g}

  Frequency of mouse pathogens           Frequency of rat pathogens               
  -------------------------------------- ---------------------------- ----------- ----
  MHV                                    61                           SDAV        21
  *M*. *pulmonis*                        29                           RPV         7
  MHV, *M*. *pulmonis*                   26                           SDAV, RPV   3
  MHV, MVM                               18                                       
  MHV, MVM, *M*. *pulmonis*              09                                       
  MHV, MVM, SeV, *M*. *pulmonis*         02                                       
  MHV, MVM, LCMV, SeV, *M*. *pulmonis*   01                                       

MHV, mouse hepatitis virus; *M*. *pulmonis*, *Mycoplasma pulmonis*; MVM, minute virus of mice; SeV, Sendai virus; LCMV, lymphocytic choriomeningitis virus.

The prevalence of various mouse and rat pathogens in southern and northern parts of India was also analyzed. More number of samples was procured from South India, which include Karnataka, Tamilnadu, Andhra Pradesh, Maharashtra and Kerala States, where the majority of the animal facilities are located. The northern states include the States of Gujarat, West Bengal, Haryana, Delhi and Uttar Pradesh. It was observed that the incidence of MHV and *Mycoplasma pulmonis* in mice was more in North India (57.14% and 31.42%, respectively) compared to South India (43.15% and 18.94%, respectively), and the only positive sample for LCMV was from North India. In rats, the incidence of SDAV and RPV was higher in North India (25.71% and 11.42%, respectively) compared to South India (12.63% and 3.15%, respectively) ([Table 3](#pone.0131706.t003){ref-type="table"}). Overall, the incidence of rodent pathogens in North India was significantly higher than in South India (p = 0.0047).

10.1371/journal.pone.0131706.t003

###### Incidence (%) of mouse and rat pathogens in North (35 samples) and South (95 samples) India.

![](pone.0131706.t003){#pone.0131706.t003g}

  Pathogen                                    South India   North India
  ------------------------------------------- ------------- -------------
  Mouse hepatitis virus (MHV)                 43.15         57.14
  *Mycoplasma pulmonis*                       18.94         31.42
  Minute virus of mice (MVM)                  11.57         20.00
  Sendai virus (SeV)                          1.05          5071
  Lymphocytic choriomeningitis virus (LCMV)   0.00          2.85
  Sialodacryoadenitis virus (SDAV)            12.63         25.71
  Rat parvo virus (RPV)                       3.15          11.42

Further analysis of the results showed that the incidence of MHV was more in Uttar Pradesh and Kerala followed by Karnataka, West Bengal and Gujarat ([Fig 1](#pone.0131706.g001){ref-type="fig"}). Similarly, the incidence of *Mycoplasma pulmonis* was high in Uttar Pradesh, Delhi and Kerala ([Fig 2](#pone.0131706.g002){ref-type="fig"}). Prevalence of MVM was high in West Bengal compared to other states ([Fig 3](#pone.0131706.g003){ref-type="fig"}). However, SeV was detected only in Karnataka and West Bengal ([Fig 4](#pone.0131706.g004){ref-type="fig"}). Only one sample which was positive for LCMV was from West Bengal. The incidence of SDAV in rat colonies was observed in six different states whereas samples from four states were negative for the same ([Fig 5](#pone.0131706.g005){ref-type="fig"}). Samples from four states tested positive for RPV ([Fig 6](#pone.0131706.g006){ref-type="fig"}).

![Incidence of mouse hepatitis virus (MHV) in different states of India.\
Yellow---25.01 to 50.00%; Blue---50.01 to 75.00%; Red---75.01 to 100.00%.](pone.0131706.g001){#pone.0131706.g001}

![Incidence of *Mycoplasma pulmonis* in different states of India.\
Green---00.00 to 25.00%; Yellow---25.01 to 50.00%; Blue---50.01 to 75.00%.](pone.0131706.g002){#pone.0131706.g002}

![Incidence of minute virus of mice (MVM) in different states of India.\
Green---00.00 to 25.00%; Yellow---25.01 to 50.00%; Blue---50.01 to 75.00%.](pone.0131706.g003){#pone.0131706.g003}

![Incidence of Sendai virus (SeV) in different states of India.\
Green---00.00 to 25.00%.](pone.0131706.g004){#pone.0131706.g004}

![Incidence of Sialodacryoadenitis virus (SDAV) in different states of India.\
Green---00.00 to 25.00%; Yellow---25.01 to 50.00%; Blue---50.01 to 75.00%.](pone.0131706.g005){#pone.0131706.g005}

![Incidence of rat parvovirus (RPV) in different states of India.\
Green---00.00 to 25.00%; Yellow---25.01 to 50.00%.](pone.0131706.g006){#pone.0131706.g006}

Data were also analyzed to determine the microbial load in public and private vivaria. In general, it was observed that the frequency of detection of pathogens was higher in vivaria of public institutes than animal facilities of private organizations. Particularly, the incidence of MHV and *Mycoplasma pulmonis* was 65.45% and 32.73% respectively, in public institutes but only 33.33% and 14.67% respectively, in private organizations. However, the incidence of MVM was more in private (17.33%) compared to public (9.09%) organizations ([Table 4](#pone.0131706.t004){ref-type="table"}). On the other hand, there was not much difference in the incidence of rat pathogens between public and private vivaria ([Table 4](#pone.0131706.t004){ref-type="table"}). Statistically, however, there was no difference overall in the incidence of rodent pathogens between public and private organizations (p = 0.9605). The results of various mouse ([S1 Table](#pone.0131706.s001){ref-type="supplementary-material"}) and rat ([S2 Table](#pone.0131706.s002){ref-type="supplementary-material"}) pathogens in various institutes are provided as supplementary information.

10.1371/journal.pone.0131706.t004

###### Incidence of various pathogens in public (55 samples) and private (75 samples) vivaria.

![](pone.0131706.t004){#pone.0131706.t004g}

  Pathogen                                                                             Public                           Private
  ------------------------------------------------------------------------------------ -------------------------------- --------------------------------
  Mouse hepatitis virus (MHV)                                                          65.45%                           33.33%
  *Mycoplasma pulmonis*                                                                32.73%                           14.67%
  Minute virus of mice (MVM)                                                           9.09%                            17.33%
  Sendai virus (SeV)                                                                   0.00%                            4.00%
  Lymphocytic choriomeningitis virus (LCMV)                                            0.00%                            1.33%
  Ectromelia virus (ECTV)                                                              0.00%                            0.00%
  Sialodacryoadenitis virus (SDAV)                                                     12.73%                           18.67%
  Rat parvo virus (RPV)                                                                7.27%                            4.00%
  Kilham's rat virus (KRV)                                                             0.00%                            0.00%
  Overall (no. of samples positive for at least one pathogen / total no. of samples)   53.33% for mice14.67% for rats   33.33% for mice25.33% for rats

Discussion {#sec007}
==========

The information on the prevalence rates of infections among laboratory animals has contributed to a better understanding of the epidemiology of these infections \[[@pone.0131706.ref016]\], as well as to judiciously implement health monitoring. The most common viral pathogens reported are norovirus, polyoma virus, K virus \[[@pone.0131706.ref017]\], \[[@pone.0131706.ref018]\], MHV, pneumonia virus of mice (PVM), reovirus, mouse parvovirus (MPV), rotavirus and SeV in mice, and PVM, SeV, SDAV, RPV, rotavirus and H-1 virus in rats \[[@pone.0131706.ref019]\]--\[[@pone.0131706.ref022]\]. Prevalence of various pathogens in mouse and rat colonies has been well documented in the US and Canada \[[@pone.0131706.ref018]\], \[[@pone.0131706.ref020]\], \[[@pone.0131706.ref023]\], Europe \[[@pone.0131706.ref016]\], \[[@pone.0131706.ref019]\], \[[@pone.0131706.ref021]\], Australia \[[@pone.0131706.ref024]\], South Africa \[[@pone.0131706.ref025]\], Brazil \[[@pone.0131706.ref026]\] and Argentina \[[@pone.0131706.ref027]\]. As far as Asia is concerned, reports are only available for Japan \[[@pone.0131706.ref028]--[@pone.0131706.ref029]\], South Korea \[[@pone.0131706.ref031]\], \[[@pone.0131706.ref032]\] and Taiwan \[[@pone.0131706.ref033]\]. There is no report documenting the prevalence of laboratory animal pathogens, except helminths, in India, and this is the first such report.

The prevalence rates of MHV, MVM and *M*. *pulmonis* in mice and SDAV and RPV in rats in India is much higher than that in developed countries where the incidence of any pathogen is typically less than 5% \[[@pone.0131706.ref007]\], \[[@pone.0131706.ref016]\], \[[@pone.0131706.ref024]\], \[[@pone.0131706.ref027]\], \[[@pone.0131706.ref030]\]. Of relevance to this study, prevalence rates of MHV, *M*. *pulmonis* and SeV in mouse colonies in South Korea and Taiwan, the closest Asian countries to India, range from 3.4% to 85%, 0.4% to 69% and 0% to 100%, respectively \[[@pone.0131706.ref031]\]--\[[@pone.0131706.ref033]\]. The prevalence rates of SDAV, RPV, KRV and SeV in rat colonies in South Korea and Taiwan range from 0% to 11.2%, 0% to 22.7%, 0% to 9.2% and 0% to 27.3%, respectively \[[@pone.0131706.ref031]--[@pone.0131706.ref033]\]. On the other hand, SeV and KRV prevalence in rats was lower in India than in Korea and Taiwan (0% versus up to 27.3% and 0% versus up to 6.25%, respectively). Our results show that although pathogen prevalence is mostly similar throughout the world, some inter-regional differences are apparent. We would like to point out that we did not test for the prevalence of murine noroviruses, which are reported to be highly prevalent among animal colonies worldwide.

Out of the six pathogens tested for mice, incidence of MHV was high in India. Being very susceptible to heat, detergents, desiccation and disinfectants, MHV would not be expected to sustain in the environment but its high prevalence may be due to its highly contagious nature \[[@pone.0131706.ref007]\], and the fact that it is shed in feces in large quantities for as long as four weeks after infection \[[@pone.0131706.ref034]\]. By contrast, the significant prevalence of parvoviral infections in rats can be attributed to their resistance to many of the common disinfectants, and stability in the environment \[[@pone.0131706.ref035]\] in addition to prolonged fecal shedding, leading to persistence of RPV in rat colonies \[[@pone.0131706.ref036]\]. On the other hand, the low incidence of MVM in mice could be due to the low sensitivity of these pathogens to serology-based tests, especially ELISA. Reportedly, MVM native antigens serve as poor targets over recombinant viral antigens for serological detection. In addition, similar disease can be caused by numerous genotypically different parvoviruses, producing false-positive reactions. In fact, recent studies in mice have shown that 90% of parvovirus infections detected by serology are due to MPV or related viruses rather than MVM, which appears to be responsible for only 5--10% of the parvovirus infections \[[@pone.0131706.ref022]\].

In comparison to corona and parvoviruses, ECTV and LCMV were rare or not recorded in the present study. Similar absence of serological evidence of LCMV and ECTV infection was noted in 1978 in the UK, and in the last decade in Australia \[[@pone.0131706.ref019]\], \[[@pone.0131706.ref024]\]. This could be due to some intrinsic characteristic/biology of these pathogens or that of the host or a combination of both.

The incidence of MHV and *M*. *pulmonis* was higher in laboratory animal colonies from public institutes compared to those of private organizations. A major contributor to this may be the use of barrier facilities by private organizations, which usually house a large number of transgenic animals. Despite the disagreement in prevalence, it must be noted that there was no overall statistically significant difference. However, further scrutiny revealed that the lack of overall significant difference could have been due to more number of public institutions each with fewer positive samples as against more number of positive samples in fewer private organizations, resulting in comparable proportions of positive samples overall. On the other hand, the incidence of rodent pathogens was significantly higher in North India compared to South India, and this may be due to the fact that more number of samples was from public entities. However, these results on either public versus private organizations or North versus South India should be interpreted with caution as the number of samples is low and not proportional to the colony size or to the density of vivaria in an area. Therefore the data have the potential to either overestimate or underestimate prevalence rates. Other limitations of the study include the small number of pathogens tested, as well as the lack of confirmatory tests. A more extensive study encompassing more organizations with more number of samples per organization over a period of time, which could not be done due to the prohibitive costs of the commercial kits, is needed to arrive at a more definitive conclusion.

Conclusion {#sec008}
==========

A preliminary study was carried out to determine the sero-epidemiology of rodent pathogens in public and private organizations in different parts of India. It was observed that MHV, *Mycoplasma pulmonis* and MVM were common in mouse colonies, and that SDAV and RPV were common in rat colonies. Presence of two or more pathogens was not uncommon especially in mice. By contrast, incidence was zero for ECTV in mice and SeV and KRV in rats. It was observed that incidence of MHV and *Mycoplasma pulmonis* were high in animal facilities, and the incidence of pathogens was significantly more in northern part of India.

Supporting Information {#sec009}
======================

###### Results for various mice pathogens.

Note: OD values \>0.30 were considered as positive as per the instructions by the ELISA kit manufacturer.
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Click here for additional data file.

###### Results for various rat pathogens.

Note: OD values \>0.30 were considered as positive as per the instructions by the ELISA kit manufacturer.
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Click here for additional data file.
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